Medicare Enrolled
Dr. Sadia Qazi, MD
Internal Medicine · Trenton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qazi
Dr. Sadia Qazi is an internal medicine specialist in Trenton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Qazi performed 4,612 Medicare services across 1,521 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qazi received a total of $5,622 from 40 pharmaceutical and/or device companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NJ
$5,622 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,612
Medicare services
Top 6% in NJ for internal medicine
1,521
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~231 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,309 | $51 | $85 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
841 | $107 | $225 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
439 | $41 | $82 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
319 | $60 | $95 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
129 | $12 | $45 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
118 | $1 | $35 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
114 | $40 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
101 | $12 | $35 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
94 | $36 | $73 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
90 | $33 | $45 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $48 | $85 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
85 | $27 | $45 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
84 | $107 | $173 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
71 | $68 | $125 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
70 | $61 | $130 |
| Annual alcohol misuse screening, 5 to 15 minutes | 70 | $20 | $26 |
| Annual depression screening | 69 | $20 | $55 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
67 | $113 | $233 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
66 | $137 | $175 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
60 | $113 | $188 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
48 | $72 | $90 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $77 | $115 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
43 | $33 | $55 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
42 | $16 | $32 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
36 | $236 | $350 |
| Recombinant quadrivalent influenza vaccine A flu shot that protects against four strains of influenza virus. It is produced using recombinant DNA technology rather than growing the virus in eggs. |
32 | $72 | $88 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
24 | $73 | $140 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
19 | $152 | $240 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
16 | $23 | $65 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
14 | $33 | $85 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
11 | $48 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,622
Total received (2018-2024)
Avg $803/year across 7 years
Top 14% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,491 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$131 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,132
2023
$1,042
2022
$661
2021
$565
2020
$766
2019
$755
2018
$701
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$293
Novo Nordisk Inc
$163
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$109
Teva Pharmaceuticals USA, Inc.
$67
Lilly USA, LLC
$66
GlaxoSmithKline, LLC.
$59
Amgen Inc.
$58
Lundbeck LLC
$54
SHIELD THERAPEUTICS INC
$38
Vifor Pharma, Inc.
$33
Exact Sciences Corporation
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Otsuka America Pharmaceutical, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$14
Neurocrine Biosciences, Inc.
$13
Top 3 companies account for 50.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,344
Novo Nordisk Inc
$684
Lilly USA, LLC
$605
Boehringer Ingelheim Pharmaceuticals, Inc.
$430
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$367
SANOFI-AVENTIS U.S. LLC
$244
Astellas Pharma US Inc
$222
Bayer Healthcare Pharmaceuticals Inc.
$192
Amgen Inc.
$157
Novartis Pharmaceuticals Corporation
$140
Merck Sharp & Dohme Corporation
$130
GlaxoSmithKline, LLC.
$96
Teva Pharmaceuticals USA, Inc.
$94
Amarin Pharma Inc.
$93
Takeda Pharmaceuticals U.S.A., Inc.
$77
Endo Pharmaceuticals Inc.
$69
SANOFI PASTEUR INC.
$58
Lundbeck LLC
$54
Neurocrine Biosciences, Inc.
$52
Otsuka America Pharmaceutical, Inc.
$49
Vifor Pharma, Inc.
$48
Bayer HealthCare Pharmaceuticals Inc.
$47
SHIELD THERAPEUTICS INC
$38
Daiichi Sankyo Inc.
$30
Biohaven Pharmaceutical Holding Company Ltd.
$29
Cumberland Pharmaceuticals, Inc.
$29
Merck Sharp & Dohme LLC
$27
Allergan, Inc.
$25
Shield Therapeutics Inc
$25
Sumitomo Pharma America, Inc.
$21
Exact Sciences Corporation
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Gilead Sciences, Inc.
$15
Avanir Pharmaceuticals, Inc.
$14
Medicure Pharma Inc.
$14
Janssen Pharmaceuticals, Inc
$14
Synergy Pharmaceuticals Inc
$14
IRONWOOD PHARMACEUTICALS, INC
$13
Seqirus USA Inc
$13
Vanda Pharmaceuticals Inc.
$11
Top 3 companies account for 46.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · ANORO · AUSTEDO · Amitiza · Austedo XR · BAQSIMI · BASAGLAR · BELSOMRA · BREZTRI · CAPLYTA · Cologuard Collection Kit · ENTRESTO · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE QUADRIVALENT · Fluad · GEMTESA · HETLIOZ · HUMALOG · INGREZZA · INJECTAFER · JANUVIA · JARDIANCE · KRISTALOSE · Kerendia · Kristalose 20gm · LINZESS · LOKELMA · Linzess · MOTEGRITY · MOUNJARO · MYRBETRIQ · NASCOBAL · NUEDEXTA · NURTEC ODT · Nuedexta · Otezla · Ozempic · RELISTOR · REXULTI · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Trintellix · Trulance · VESICARE · VRAYLAR · Vascepa · Veltassa · Vemlidy · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,739
Per 100K population
453.7
County median income
$96,333
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT HAMILTON
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qazi is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NJ), with low-engagement industry engagement in the top 14% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qazi experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Qazi performed 1,309 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qazi receive payments from pharmaceutical companies?
Yes. Dr. Qazi received a total of $5,622 from 40 companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qazi's costs compare to other internal medicine physicians in Trenton?
Dr. Qazi's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Trenton
Browse internal medicine physicians in Trenton ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology